INTRODUCTION
Reduced plasma concentrations of the third component of complement (C3) are a feature of certain forms of glomerular disease, including acute post-streptococcal glomerulonephritis (AGN),' nephritis complicating sysDr. Charlesworth was the recipient of a Commonwealth Scholarship.
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1 Abbreviations used in this paper: AGN, acute poststreptococcal glomerulonephritis; C3NeF, C3 nephritic factor; CoF, purified cobra factor; C3PA, C3 proactivator; EV/IV, extravascular/intravascular distribution ratio; temic lupus erythematosus (SLE), and mesangiocapillary glomerulonephritis (MCGN) . Such hypocomplementemia may be accompanied by evidence of activation of C1, C4, and C2, indicating involvement of the classical pathway (as in SLE) or of an alternative pathway, where C3 activation is independent of these components. Of special interest has been the finding of a circulating C3 activator-the so-called C3 nephritic factor (C3NeF) -in the serum of patients with MCGN (1-3). More recently hypocomplementemia and a factor closely resembling C3NeF have been demonstrated in the serum of patients, with partial lipodystrophy (PLD) (4, 5) .
We have demonstrated that C3NeF causes C3 breakdown by activation of the C3b-feedback cycle, a mechanism independent of C4 and C2 (6) . A major constituent of the C3b-feedback is the glycine-rich 8-glycoprotein (GBG), now known to be identical with the C3 proactivator of Gotze and Muller-Eberhard (7) and factor B munochemical removal of KAF from normal human serum (9) .
To examine the relationship between C3 activation and activation of the C3b-feedback cycle, we have studied the metabolism of radioactive labeled C3 and GBG in a variety of patients with hypocomplementemia. No studies of GBG metabolism in health or disease have yet been reported but previous studies of C3 metabolism in patients with hypocomplementemic MCGN have given variable results. Some workers (13, 3) have found reducd C3 synthesis, while others (14, 15) have found accelerated C3 catabolism to be the major immediate cause of hypocomplementemia. METHODS
Subjects
Normal controls. 18 healthy members of the medical and technical staff received one or both labeled proteins:
Patients. Two groups of patients were studied. The first (22 patients) -had diseases associated with hypocomplementemia. These were: MCGN, six patients; MCGN plus PLD, four patients; PLD without renal disease, two patients; SLE, five patients; AGN, three patients; one patient with recurrent urticaria of the type recently reported by McDuffie, et al. (16) ; and a patient with mixed cryoglobulinemia and glomerulcnephritis, probably induced by repeated self-administration of a vaccine containing diphtheria and tetanous toxoids, and Hemophilus pertussis (17) . The second group (11 patients) had various renal diseases with normal serum complement. The diagnoses were: chronic glomerulonephritis, six patients; acute tubular necrosis, two patients; focal glomerlonephritis, one patient; Goodpasture's syndrome, one patient; and membranous nephropathy associated with carcinoma of the bronchus, one patient.
Purification of complement components C3, GBG, and KAF were prepared from hepatitis Bantigen-free serum obtained from healthy volunteers. A full description of preparative techniques is given by Lachmann, Hobart, and Aston (18) . The purity of C3 and GBG was tested by immunoelectrophoresis and Ouchterlony gel analysis with antibodies specific for C3, GBG, and whole human serum. KAF was functionally tested by the method of Lachmann et al. (18) .
Radio-iodination
Proteins were labeled with 'I or 'S1I by a modification of the chloramine-T method (19, 20) . Human serum was added to the labeled proteins to reduce self-irradiation and the preparations were sterilized by Millipore filtration and pyrogen-tested as described elsewhere (20) . Autoradiography of immunoelectrophoresis against antibody to whole serum revealed insignificant amounts of labeled contaminants, and precipitation with mono-specific antisera removed 90%c of radioactivity of labeled C3 and 94%,o of GBG.
Assessment of biological activity of labeled preparations C3. Radiolabeled C3 was tested for hemolytic and conglutination activities (18) Lachmann (21) and Nicol and Lachmann (9) . The capacity of labeled GBG to produce a cobra-factor-dependent C3-convertase was then tested by incubation with purified cobra factor (CoF) and R (GBG). The activity of the C3-convertase generated was measured by the lysis of guinea pig erythrocytes in the presence of human EDTA serum (18 of the study and the doses of radioactivity (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) uCi) were approved by the Medical Research Council. Thyroidal uptake of iodide was blocked by oral potassium iodide, 180 mg daily for 3 days, before radioactivity was administered. Each study was continued for 5-7 days. Plasma and urine specimens were processed as described by Charlesworth, Williams, Sherington, and Peters (20) . Assessment of red-cell-bound radioactivity. In seven subjects, red-cell-bound radioactivity was measured. This group included two normal volunteers, two patients with PLD, 
Methods of analysis of turnover data
Only data from patients judged to be in a steady state, i.e. in whom the serum concentration of GBG or C3 varied by less than 20%o during the turnover studies, were included for analysis. The turnover data were analyzed by the following methods: urine/plasma ratios (23) ; exponential analysis (24) ; and integrated rate analysis (25) , as previously applied (20) .
Statistical analysis. Regression analyses were carried out by the method of least squares, and a nonparametric regression analysis used Spearman's ranked correlation coefficient. 2) fell within the normal range (10-50 mg/100 ml).
RESULTS

Normal subjects
GGG was never detected in fresh plasma. KAF levels were normal in all patients. Significant reduction in serum properdin (less than 40% of reference serum) occurred in four patients: two MCGN, one SLE, and one AGN (Fig. 3) .
METABOLIC DATA C3 Types of disappearance curve and their analysis. In patients with renal failure and iodide retention it was necessary to apply Matthew's analysis (24) to the plasma curves. It became evident that in patients with hypercatabolism, two types of plasma curve occurred (Fig. 4) (Fig. 11) . Inclusion of all subjects (13 patients and 4 normals) produced no significant relationship between catabolic rates of C3 and GBG (r = 0.27, P > 0.1). However, exclusion of the six patients with C3d in plasma again left a residual group with a significant correlation (r = 0.83, P < 0.01).
Serum properdin and C3 and GBG catabolism (Figs. 3,12 GBG metabolism 10 out of 23 patients had FCR GBG greater than 2.2%/h. There was a significant inverse correlation between GBG concentration and FCR GBG (Fig. 2) but no relationship between GBG synthesis and GBG levels (Fig. 9) . Synthesis values varied widely, being slightly reduced in one patient had normal or elevated in the remainder.
Interrelationships between C3 and GBC metabolism C3 concentration vs. FCR GBG (Fig. 10) . No correlation was observed (r =-0.428, P> 0.05). However, Our results show that hypercatabolism and depressed C3 synthesis occur together in patients with hypocomplementemia, either when complement is activated by the classical pathway (involving C1, C4, and C2) or when activation is known to be independent of these components, as occurs in MCGN (6) and in PLD (5) . Depressed C3 synthesis has also been reported in hypocomplementemic SLE by Sliwinski and Zvaifler (26) . More detailed scrutiny of plasma protein radioactivity curves showed a complex pattern in some patients; this pattern is characterized by a rapid early clearance of radioactivity from the plasma, followed by a slowing of the disappearance rate, so that in some instances the slope finally reached a half-life greater than normal. In our patients with normal renal function, daily estimates of FCR showed high initial rates of catabolism, which fell into the normal range after 3-4 days. Analysis of total body radioactivity curves also indicated an abnormally high proportion of the C3 to be extravascular, suggesting extravascular sequestration of the label. We have found similar patterns of C3 turnover in rabbits in which C3 activation was caused by administration of CoF (27) . In these animals, it was possible to demonstrate hypercatabolism and extravascular sequestration of C3 and to show that the slow phase of the plasma curve was associated with circulating labeled C3d, as shown by autoradiography of immunoelectrophoresis of fresh plasma. The doses of radioactivity used in our human studies were insufficient to permit such identification of labeled proteins, but all patients showing this pattern of early rapid catabolism had C3d detectable in fresh plasma samples. The complexity of C3 catabolism in such patients means that measurement of catabolic rates must be based on observations obtained during the first or second day of the turnover study, before C3d becomes the predominant labeled protein. This is undesirable, since denaturation of the protein may introduce errors, but there is no alternative method of avoiding the problem. Errors due to denaturation were minimized by the use of one highly purified C3 preparation and every patient was studied simultaneously with a healthy volunteer.
Our findings show that in addition to hypercatabolism, reduction in C3 synthesis is a major determinant of hypocomplementemia. This conclusion is supported by the in vitro observations of Colten, Levey, Rosen, and
Alper (28) Our studies on the catabolism of GBG showed that this was a rapidly metabolized protein with fractional rates of catabolism comparable to C3. Unlike C3, no significant alterations in GBG synthesis rates were observed in patients with complement activation. The concentrations of GBG in the serum of healthy subjects may vary widely (29) ,' but in the seven normal subjects in whom its turnover was studied, the GBG concentrations fell within a close range. We therefore do not know if the variation in serum concentrations amongst healthy subjects is due to variation in synthesis or catabolism.
The rate of turnover of GBG was used as a measure of activation of the C3b-feedback cycle. Stimulation of this cycle by C3b must depend on C3 synthesis, C3b generation by C3 activation, and C3b inactivation by KAF. In no patient was there significant lowering of KAF concentrations in serum; it therefore seems likely that C3b-feedback activity in this group of patients is principally related to C3 synthesis and C3 activation. On theoretical grounds, it could be anticipated that a moderate degree of C3 activation, associated with relatively little reduction in C3 synthesis, would generate more C3b and cause a faster turnover of GBG than would more marked degrees of C3 activation, where reduction in C3 synthesis could limit C3b generation. When patients with C3d (who had the most marked reduction in C3 synthesis) were excluded, there was a significant correlation between the FCRs of C3 and GBG, but this correlation was lost when patients with circulating C3d were included; thus one patient with MCGN and PLD (Fig. 11) 
